Recombinant Campylobacter jejuni subsp. jejuni serotype O:2 Major outer membrane protein (porA)

What is the structure and function of Campylobacter jejuni PorA protein?

PorA, the major outer membrane protein (MOMP) of Campylobacter jejuni, exists in three conformational forms: folded monomer (35 kDa), denatured monomer (45 kDa), and native trimer (120-140 kDa). Only the folded monomer and native trimer demonstrate pore-forming activities . The protein consists of 18 β-strands connected by short periplasmic turns and nine external loops that are antigenically variable . These β-strands represent conserved regions with common antigenic epitopes across different strains .

Functionally, PorA serves as a cationic porin involved in ion transport across the bacterial cell wall and adhesion to intestinal mucosa . The protein's surface-exposed conformational epitopes are important in host immunity, with variation in these regions likely occurring due to positive immune selection during infection . This structural arrangement allows PorA to function as a key interface between the bacterium and its environment, potentially playing crucial roles in adaptation to various hosts .

How does genetic diversity of porA manifest across Campylobacter strains?

The porA gene of Campylobacter jejuni and Campylobacter coli exhibits extraordinary genetic diversity. In a study examining 584 isolates from a defined human population over one year, researchers identified 196 distinct porA variants . This diversity is characterized by:

• Seven highly variable regions interspersed among conserved sequences

• Regions encoding putative extracellular loops showing the most variation in both nucleotide sequence and length

• Evidence of positive selection, with non-synonymous substitutions exceeding synonymous substitutions

Phylogenetic analysis of porA alleles reveals three distinct clusters:

• Predominantly C. jejuni with a few C. coli isolates

• Solely C. jejuni isolates

• Predominantly C. coli with a few C. jejuni isolates

This genetic diversity pattern suggests that while porA varies considerably between strains, the variations follow distinct evolutionary patterns that correlate with species boundaries, though some cross-species gene transfer may occur .

What methodologies are used for Campylobacter detection and isolation?

The detection and isolation of Campylobacter from clinical, food, and environmental samples typically employ a combinatorial approach of selective enrichment and culturing methods . The process involves several complementary techniques:

• Selective Enrichment: Utilizes specialized media containing antimicrobials that inhibit competing microflora while allowing Campylobacter to grow

• Culture-Based Methods: Involves plating on selective media followed by incubation under microaerophilic conditions (typically 5-10% oxygen, 5-10% carbon dioxide)

• Biochemical Identification: Tests for oxidase activity, hippurate hydrolysis, and other biochemical markers specific to Campylobacter species

• Immunological Approaches: Includes enzyme-linked immunosorbent assays (ELISA) and immunofluorescence techniques for rapid detection

• Molecular Detection: Nucleic acid-based methodologies such as PCR targeting conserved genes (including porA) for identification and differentiation of Campylobacter isolates

These methods are essential in foodborne outbreak investigations and for assessing the diversity and phylogenetic relationships of these bacterial pathogens . The combination of approaches provides a comprehensive framework for accurate detection and characterization of Campylobacter species in various sample types.

What expression systems are most effective for producing recombinant PorA protein?

Expression of recombinant PorA requires careful consideration of several factors to ensure proper protein folding and maintenance of conformational epitopes. Based on the research literature, several approaches have proven effective:

• E. coli-Based Expression Systems: The pET expression system has been successfully employed for PorA production. For example, pET-32a vector transformed into Origami B (DE3) cells has been used to express recombinant PorA . This system includes:

  • IPTG induction (optimal at 1.0 mmol/L concentration)

  • Expression resulting in a fusion protein of approximately 65 kDa

  • Protein typically expressed as inclusion bodies

• Purification Strategies:

  • Affinity purification using Ni-NTA agarose for His-tagged recombinant proteins

  • Sarkosyl-purification methods for native MOMP extraction from Campylobacter

  • Proper refolding protocols to maintain conformational epitopes

• Verification Methods:

  • SDS-PAGE for size verification and purity assessment

  • Western blotting using antibodies raised against native outer membrane vesicles to confirm antigenic properties

The expression efficiency varies based on induction conditions, with researchers reporting that IPTG at 1.0 mmol/L effectively induces protein expression in prokaryotic systems . Critically, recombinant PorA should retain reactivity with antibodies raised against native protein to ensure conformational integrity for downstream applications.

How stable is the porA gene during infection, and what implications does this have for vaccine development?

The stability of the porA gene during infection is a critical consideration for its use in both typing schemes and vaccine development. Studies examining the longitudinal stability of porA during human infections provide valuable insights:

• Stability During Typical Infections:

  • In a study of 37 patients with typical illness duration (0-4 days), no porA mutations were detected

  • Family outbreak investigations showed consistent porA profiles among individuals in the same household

• Evidence of Mutation During Prolonged Infection:

  • In two patients with prolonged illness (5-34 days), evidence of porA mutation was detected

  • Patient 55: G to A transition resulting in glycine to aspartic acid substitution in loop 7 (non-conservative change)

  • Patient 59: Histidine insertion (CAT repeat) in loop 8

• Mutation Characteristics:

  • Mutations occurred exclusively in putative surface-exposed loops

  • Changes were non-synonymous, suggesting positive immune selection

  • No synonymous nucleotide changes were observed

These findings have significant implications for vaccine development:

• The general stability of porA in most infections suggests it can serve as a reliable vaccine target

• Mutations during prolonged infection indicate immune pressure on surface-exposed regions

• Vaccine designs should account for potential variation in these immunogenic loops, potentially by including multiple variants or targeting conserved regions

• Despite variability, the persistence of numerous variants in the population supports porA's suitability for extended typing schemes

What evidence supports the efficacy of recombinant PorA as a vaccine candidate against Campylobacter infection?

Recombinant PorA shows promising potential as a vaccine candidate against Campylobacter infection, with several lines of evidence supporting its efficacy:

• Heterologous Protection in Mouse Models:

  • Adult BALB/c mice orally immunized with recombinant GST-PorA fusion protein showed significant protection against heterologous strain challenge

  • Protection efficacies against heterologous strains were:

    • 43% for strain 48 (O:19) (P < 0.001)

    • 29% for strain 75 (O:3) (P < 0.005)

    • 42% for strain 111 (O:1,44) (P < 0.001)

• Robust Immune Response:

  • The vaccine produced strong antibody responses in both serum and intestinal secretions

  • Antibodies recognized both the vaccine antigen and Sarkosyl-purified MOMP from the original strain

• Common Antigen Across Serotypes:

  • While C. jejuni immunity is generally serotype-specific, PorA represents a common antigen shared across serotypes

  • The β-strands of PorA contain common antigenic epitopes across different strains, providing a basis for broad protection

• Advantages for Vaccine Development:

  • PorA is abundant in Campylobacter, increasing its availability as an immunogen

  • Despite genetic diversity, conserved regions offer potential targets for broad-spectrum immunity

  • Proven immunogenicity in animal models suggests potential for human applications

These findings indicate that recombinant PorA can provide appreciable protection against colonization with heterologous serotypes, addressing the challenge of serotype-specific immunity that has complicated Campylobacter vaccine development .

How does the genetic diversity of porA impact typing schemes for epidemiological investigations?

The genetic diversity of porA makes it a valuable marker for epidemiological typing, but this diversity must be properly characterized and understood for effective implementation:

• Discriminatory Power:

  • The level of diversity observed at the porA locus is significantly greater than that at housekeeping loci used in MLST (Multilocus Sequence Typing)

  • Nearly every distinct nucleotide sequence encodes a novel peptide, providing high discriminatory power for distinguishing isolates

• Stability Considerations:

  • Despite high diversity, porA remains stable during most human infections, making it suitable for epidemiological investigations

  • In a study of 64 sporadic cases and 20 family outbreaks, evidence of mutation was detected in only two patients with prolonged illness

• Implementation in Extended Typing Schemes:

  • porA diversity has been exploited in genotyping studies to identify potentially epidemiologically linked cases of human campylobacteriosis

  • A highly discriminatory typing scheme extends the MLST approach by incorporating porA and the SVRs of flagellin genes flaA and flaB

• Phylogenetic Utility:

  • porA sequences can be used to identify three distinct allele clusters, providing insight into species relationships between C. jejuni and C. coli

  • This phylogenetic information helps understand transmission patterns and source attribution in outbreak investigations

The persistence of numerous variants within the population indicates that the porA allele is a valuable tool for use in extended typing schemes despite evidence of positive immune selection in some cases . Researchers should be aware that while rare, mutations can occur during prolonged infections, potentially complicating epidemiological interpretations in such cases.